AI in Pharma: Benefits, Risks, and the Road Ahead

Use of artificial intelligence (AI) now permeates every industry, and pharma is no exception. Whether machine learning (ML) models that make predictions based on existing data or generative AI (GenAI) models that create new data based on the data they were trained on, AI is being used to streamline and accelerate each step of the drug development process from research through approval and marketing.

First Name *

Last Name *

Company *

Job Title *

Department

Business Email Address *

Country *

Business Phone *

How Can We Help

fieldlabel

Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Related resources

AI assistant in biotechnology science experiment

JUL 15, 2024

Article

Clinical

The Promise and Peril of AI in Clinical Trials

Many smaller organizations have not yet implemented a specialized clinical trial disclosure system. Robust transparency, and perhaps even just compliance with multiple regulators, requires commitment from the C-suite for companies of all sizes.

SEP 05, 2024

Article

Clinical

The Real Value of Synthetic Data in Clinical Research: 3 Use Cases

Synthetic data, a form of generative AI, focuses on the creation of new content. See three use cases for using synthetic data in clinical research.

NOV 09, 2023

Video

Clinical

The Cutting Edge of Pharma: AI and RWD

Thought leaders from Norstella and Citeline shared their expert insights on artificial intelligence and real-world data at the CNS Summit.

View all